rufinamide

FDA Drug Profile — Banzel, RUFINAMIDE, Rufinamide, rufinamide

Drug Details

Generic Name
rufinamide
Brand Names
Banzel, RUFINAMIDE, Rufinamide, rufinamide
Application Number
NDA201367
Sponsor
Eisai Inc.
NDC Codes
11
Dosage Forms
SUSPENSION, TABLET, FILM COATED, POWDER
Routes
ORAL
Active Ingredients
RUFINAMIDE

Indications and Usage

1 INDICATIONS AND USAGE Rufinamide oral suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults. Rufinamide oral suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults ( 1 )